Hyuk‐Jae Chang

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Age- and Sex-Related Differences in All-Cause Mortality Risk Based on Coronary Computed Tomography Angiography Findings

James K. Min, Allison Dunning, Fay Y. Lin et al. · Journal of the American College of Cardiology · 2011 · 751 citations · Full text

All-cause Mortality Risk, Cardiovascular Disease, Longevity +12

Machine learning for prediction of all-cause mortality in patients with suspected coronary artery disease: a 5-year multicentre prospective registry analysis

Manish Motwani, Damini Dey, Daniel S. Berman et al. · European Heart Journal · 2016 · 700 citations · Full text

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

Metabolic Syndrome, Diabetes Management, Urology +10

Effects of Statins on Coronary Atherosclerotic Plaques

Sang‐Eun Lee, Hyuk‐Jae Chang, Ji Min Sung et al. · JACC. Cardiovascular imaging · 2018 · 481 citations · Full text

Coronary Atherosclerotic Plaques, Cardiovascular Disease, Medicine +7